Intervention Protocol

Ultra-long acting insulin versus long-acting insulin for type 1 diabetes mellitus

  1. Cheow Peng Ooi1,*,
  2. Tzer Hwu Ting2,
  3. Seng Cheong Loke3

Editorial Group: Cochrane Metabolic and Endocrine Disorders Group

Published Online: 8 MAY 2014

DOI: 10.1002/14651858.CD011102


How to Cite

Ooi CP, Ting TH, Loke SC. Ultra-long acting insulin versus long-acting insulin for type 1 diabetes mellitus (Protocol). Cochrane Database of Systematic Reviews 2014, Issue 5. Art. No.: CD011102. DOI: 10.1002/14651858.CD011102.

Author Information

  1. 1

    Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Endocrine Unit, Department of Medicine, Serdang, Selangor DE, Malaysia

  2. 2

    Universiti Putra Malaysia, Department of Paediatrics, Faculty of Medicine and Health Sciences, Serdang, Selangor DE, Malaysia

  3. 3

    Universiti Putra Malaysia, Institute of Gerontology, Serdang, Selangor DE, Malaysia

*Cheow Peng Ooi, Endocrine Unit, Department of Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Selangor DE, 43400, Malaysia. cpooi07@gmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 8 MAY 2014

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the effects of ultra-long acting insulin compared with long-acting insulin in patients with T1DM.